Batten Disease (NCL) — NDIS Support
Yes — Batten Disease (NCL) can qualify for NDIS support. Batten Disease (NCL) is on the NDIA’s List A, so the disability requirement is treated as met — the focus is confirming the diagnosis. Funding covers reasonable and necessary supports across daily living, therapy, social participation and capacity building.
Batten disease is the common name for a group of inherited neurodegenerative disorders known collectively as neuronal ceroid lipofuscinoses (NCLs). They are characterised by the accumulation of lipopigments (ceroid and lipofuscin) in neurons and other cells throughout the body, causing progressive…
Batten Disease (NCL) & the NDIS FAQs
- Is Batten disease a List A NDIS condition?
- Yes — Batten disease (NCL) is on the NDIS List A. A confirmed diagnosis from a clinical geneticist or paediatric neurologist, supported by genetic testing identifying a causative CLN gene mutation, is sufficient for NDIS access without a separate functional impact assessment. Given the devastating and progressive…
- Is there any treatment for Batten disease?
- Cerliponase alfa (Brineura), approved by the TGA and available in Australia, is the first disease-modifying treatment for CLN2 (late infantile) Batten disease — administered by intraventricular infusion every two weeks, it significantly slows the rate of motor and language decline. Clinical trials for CLN3 (juvenile…
- How does NDIS support a family through Batten disease?
- NDIS plans for Batten disease are typically substantial and escalate over time as care needs increase. Core supports fund personal care workers and overnight support. Capital supports fund home modifications (hoists, hospital beds, wheelchair access), wheelchairs and assistive technology. Capacity Building funds allied…
- What is the difference between Batten disease and other progressive neurological conditions?
- Batten disease is specifically the NCL group — characterised by lysosomal lipopigment accumulation, vision loss, seizures, cognitive and motor decline in childhood. Other progressive neurological conditions in children include mucopolysaccharidoses (MPS, storage disorders with different biochemistry), Rett syndrome…
- Are siblings at risk if one child has Batten disease?
- Batten disease is autosomal recessive — both parents are carriers of one pathogenic CLN gene variant, without symptoms themselves. Each pregnancy has a 25% chance of an affected child, 50% chance of a carrier (unaffected), and 25% chance of non-carrier. Genetic testing of siblings at risk (particularly in CLN2 disease…
Batten Disease (NCL) & the NDIS — practical guides
- Applying for the NDIS with Batten Disease (NCL)
- Assistive Technology for Batten Disease (NCL)
- NDIS Funding & Budget for Batten Disease (NCL)
- Therapy & Allied Health for Batten Disease (NCL)
- Finding & Managing Support Workers for Batten Disease (NCL)
Related conditions
- Niemann-Pick Disease and the NDIS
- Wolf-Hirschhorn Syndrome and the NDIS
- Limb Amputation (Acquired) and the NDIS
- 22q11.2 Deletion Syndrome (DiGeorge) and the NDIS
- Achondroplasia (Dwarfism) and the NDIS
- Arthrogryposis and the NDIS
- Bardet-Biedl Syndrome and the NDIS
- CDKL5 Deficiency Disorder and the NDIS
- Cerebral Visual Impairment (CVI) and the NDIS
- Chiari Malformation and the NDIS
Sources
Reviewed by the Novida editorial team · last reviewed 2026-07-12. General information only — not medical advice.